✦ LIBER ✦

PAR6 COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

✍ Scribed by VD Patel; J Hay

Book ID: 119593047
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 45 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62130-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Of Abatacept For The

Cost-Effectiveness Of Abatacept For The Treatment Of Patients With Rheumatoid Arthritis After An Inadequate Response To Methotrexate In Chile

✍ Elgart, J.F.; Gonzalez, L.; Aiello, E.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Cost-effectiveness of abatacept in patie

Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate

✍ Vera-Llonch, M.; Massarotti, E.; Wolfe, F.; Shadick, N.; Westhovens, R.; Sofrygi 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 134 KB

Efficacy of adjunct tacrolimus treatment

Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate

✍ Mariko Kitahama, Ayako Nakajima, Eisuke Inoue, Atsuo Taniguchi, Shigeki Momohara 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 204 KB

PMS18 COST-EFFECTIVENESS OFABATACEPT IN

PMS18 COST-EFFECTIVENESS OFABATACEPT IN PATIENTS WITH MODERATELYTO SEVERELY ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN BRAZIL

✍ MR Alves; F Carvalho Jr; G Litalien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

A cost-effectiveness analysis of treatme

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis

✍ Hyon K. Choi; John D. Seeger; Karen M. Kuntz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB